# Study to Evaluate Analgesic Effect of IV Administration of Kappa Agonist CR845 For Hysterectomy Surgery

> **NCT01361568** · PHASE2 · COMPLETED · sponsor: **Cara Therapeutics, Inc.** · enrollment: 203 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** CR845
- **DRUG:** Placebo
- **DRUG:** CR845
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01361568
- **Lead sponsor:** Cara Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361568, "Study to Evaluate Analgesic Effect of IV Administration of Kappa Agonist CR845 For Hysterectomy Surgery". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01361568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*